rs61756244

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000639.3(FASLG):​c.147G>A​(p.Pro49Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00889 in 1,610,046 control chromosomes in the GnomAD database, including 1,023 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.047 ( 567 hom., cov: 32)
Exomes 𝑓: 0.0050 ( 456 hom. )

Consequence

FASLG
NM_000639.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.33

Publications

4 publications found
Variant links:
Genes affected
FASLG (HGNC:11936): (Fas ligand) This gene is a member of the tumor necrosis factor superfamily. The primary function of the encoded transmembrane protein is the induction of apoptosis triggered by binding to FAS. The FAS/FASLG signaling pathway is essential for immune system regulation, including activation-induced cell death (AICD) of T cells and cytotoxic T lymphocyte induced cell death. It has also been implicated in the progression of several cancers. Defects in this gene may be related to some cases of systemic lupus erythematosus (SLE). Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2014]
FASLG Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome type 1
    Inheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autoimmune lymphoproliferative syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 1-172659348-G-A is Benign according to our data. Variant chr1-172659348-G-A is described in ClinVar as [Benign]. Clinvar id is 293729.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.33 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.16 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FASLGNM_000639.3 linkc.147G>A p.Pro49Pro synonymous_variant Exon 1 of 4 ENST00000367721.3 NP_000630.1 P48023-1Q53ZZ1
FASLGNM_001302746.2 linkc.147G>A p.Pro49Pro synonymous_variant Exon 1 of 3 NP_001289675.1 P48023-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FASLGENST00000367721.3 linkc.147G>A p.Pro49Pro synonymous_variant Exon 1 of 4 1 NM_000639.3 ENSP00000356694.2 P48023-1
FASLGENST00000340030.4 linkc.147G>A p.Pro49Pro synonymous_variant Exon 1 of 3 1 ENSP00000344739.3 P48023-2

Frequencies

GnomAD3 genomes
AF:
0.0467
AC:
7091
AN:
151792
Hom.:
568
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.163
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0161
Gnomad ASJ
AF:
0.00289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000623
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.000559
Gnomad OTH
AF:
0.0269
GnomAD2 exomes
AF:
0.0121
AC:
2942
AN:
242834
AF XY:
0.00906
show subpopulations
Gnomad AFR exome
AF:
0.170
Gnomad AMR exome
AF:
0.00578
Gnomad ASJ exome
AF:
0.00497
Gnomad EAS exome
AF:
0.000388
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000615
Gnomad OTH exome
AF:
0.00457
GnomAD4 exome
AF:
0.00495
AC:
7218
AN:
1458138
Hom.:
456
Cov.:
32
AF XY:
0.00424
AC XY:
3073
AN XY:
725122
show subpopulations
African (AFR)
AF:
0.169
AC:
5636
AN:
33410
American (AMR)
AF:
0.00663
AC:
294
AN:
44368
Ashkenazi Jewish (ASJ)
AF:
0.00533
AC:
139
AN:
26056
East Asian (EAS)
AF:
0.000656
AC:
26
AN:
39632
South Asian (SAS)
AF:
0.000337
AC:
29
AN:
85968
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52542
Middle Eastern (MID)
AF:
0.00789
AC:
45
AN:
5702
European-Non Finnish (NFE)
AF:
0.000350
AC:
389
AN:
1110312
Other (OTH)
AF:
0.0110
AC:
660
AN:
60148
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
409
819
1228
1638
2047
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0467
AC:
7097
AN:
151908
Hom.:
567
Cov.:
32
AF XY:
0.0454
AC XY:
3375
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.163
AC:
6735
AN:
41344
American (AMR)
AF:
0.0161
AC:
245
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00289
AC:
10
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.000624
AC:
3
AN:
4808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.000559
AC:
38
AN:
67960
Other (OTH)
AF:
0.0267
AC:
56
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
275
550
825
1100
1375
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0252
Hom.:
118
Bravo
AF:
0.0531
Asia WGS
AF:
0.00895
AC:
31
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 08, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autoimmune lymphoproliferative syndrome type 1 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.19
DANN
Benign
0.57
PhyloP100
-1.3
PromoterAI
-0.0026
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61756244; hg19: chr1-172628488; COSMIC: COSV60680997; API